Department of Neurology, University of Rostock, Gehlsheimer Straße 20, 18147 Rostock, Germany.
Department of Anatomy, University of Rostock, Gertrudenstraße 9, 18057 Rostock, Germany.
Neurobiol Dis. 2021 Aug;156:105404. doi: 10.1016/j.nbd.2021.105404. Epub 2021 May 24.
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an established therapeutic principle in Parkinson's disease, but the underlying mechanisms, particularly mediating non-motor actions, remain largely enigmatic.
OBJECTIVE/HYPOTHESIS: The delayed onset of neuropsychiatric actions in conjunction with first experimental evidence that STN-DBS causes disease-modifying effects prompted our investigation on how cellular plasticity in midbrain dopaminergic systems is affected by STN-DBS.
We applied unilateral or bilateral STN-DBS in two independent cohorts of 6-hydroxydopamine hemiparkinsonian rats four to eight weeks after dopaminergic lesioning to allow for the development of a stable dopaminergic dysfunction prior to DBS electrode implantation.
After 5 weeks of STN-DBS, stimulated animals had significantly more TH dopaminergic neurons and fibres in both the nigrostriatal and the mesolimbic systems compared to sham controls with large effect sizes of g = 1.9-3.4. DBS of the entopeduncular nucleus as the homologue of the human Globus pallidus internus did not alter the dopaminergic systems. STN-DBS effects on mesolimbic dopaminergic neurons were largely confirmed in an independent animal cohort with unilateral STN stimulation for 6 weeks or for 3 weeks followed by a 3 weeks washout period. The latter subgroup even demonstrated persistent mesolimbic dopaminergic plasticity after washout. Pilot behavioural testing showed that augmentative dopaminergic effects on the mesolimbic system by STN-DBS might translate into improvement of sensorimotor neglect.
Our data support sustained neurorestorative effects of STN-DBS not only in the nigrostriatal but also in the mesolimbic system as a potential factor mediating long-latency neuropsychiatric effects of STN-DBS in Parkinson's disease.
深部脑刺激(DBS)于丘脑底核(STN)是治疗帕金森病的既定治疗原则,但其中的潜在机制,特别是介导非运动作用的机制,仍然很大程度上是个谜。
目的/假设:神经精神作用的延迟发作,加上首次实验证据表明 STN-DBS 会产生疾病修饰作用,促使我们研究 STN-DBS 如何影响中脑多巴胺能系统的细胞可塑性。
我们在两个独立的 6-羟多巴胺半帕金森大鼠队列中应用单侧或双侧 STN-DBS,在多巴胺能损伤后 4 到 8 周进行,以便在 DBS 电极植入前允许稳定的多巴胺能功能障碍发展。
在 STN-DBS 后 5 周,与假手术对照组相比,刺激动物的黑质纹状体和中脑边缘多巴胺能系统中的 TH 多巴胺能神经元和纤维明显更多,效应大小 g 为 1.9-3.4。作为人类苍白球 internus 同源物的动眼神经核的 DBS 不会改变多巴胺能系统。单侧 STN 刺激 6 周或刺激 3 周后再洗脱 3 周的独立动物队列中,STN-DBS 对中脑边缘多巴胺能神经元的影响得到了很大程度的证实。后者亚组甚至在洗脱后仍显示出持续的中脑边缘多巴胺能可塑性。初步行为测试表明,STN-DBS 对中脑边缘系统的多巴胺能增强作用可能转化为对感觉运动忽视的改善。
我们的数据支持 STN-DBS 的持续神经修复作用,不仅在黑质纹状体系统,而且在中脑边缘系统中,作为介导 STN-DBS 在帕金森病中长潜伏期神经精神作用的潜在因素。